Home > Press > Iran Produces Nanocarrier of Nutritive Compound with Anticancer Properties
Abstract:
Iranian researchers succeeded in the production of hesperetin nanocarriers by using ultrasound waves through up-to-down mechanical methods.
In addition to being eatable, the nanocarriers enjoy a high potential to be produced at industrial scale. The produced nanocarriers increased the stability of hesperetin and improved its undesirable properties.
Hesperetin is a nutritive compound with high anti-oxidant properties, which has anticancer effects and decreases blood pressure.
In this research, lipid nanocarriers containing hesperetin were produced through mechanical methods by using biocompatible compounds, and some of their properties, including the size, surface charge, thermal, crystalline, and chemical characteristics were investigated through various experiments. The release of hesperetin was also investigated in stomach and intestine conditions to determine how much the produced carriers would protect hesperetin against undesirable acidic environmental media.
Dr. Milad Fathi, one of the researchers, elaborated on the characteristics of the research, and said, "There are two major problems in the application of nanotechnology in food industry. The first one is the food safety and necessity to pay attention to the application of biodegradable materials without causing allergy. The second one is the possibility to produce at industrial scale. The project was carried out in a way that nutritive nanomaterials were completely eatable. On the other hand, the used method has the ability to be produced at industrial scale."
Results of the research have been published in details in Food and Bioprocess Technology, vol. 6, issue 6, 2013, pp. 1464-1475. The article shows the application of the product in food industry. The results of the research can also be used for the protection and controlled release of sensitive drugs.
####
For more information, please click here
Copyright © Fars News Agency
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Discoveries
Breaking carbon–hydrogen bonds to make complex molecules November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||